Both in Pharmaceuticals
Agios Pharmaceuticals vs Stoke Therapeutics
Over the past year AGIO returned −21.6% and STOK returned +8.3%; their daily moves had a correlation of 0.20.
AGIO −21.6% STOK +8.3%Growth of $1, one year, split-adjusted
| Metric | AGIO | STOK |
|---|---|---|
| Price | $31.38 | $27.45 |
| Market cap | $1.87B | $1.77B |
| Today | +0.58% | +1.70% |
| 1 month | −1.1% | +12.6% |
| 6 months | +16.3% | −17.5% |
| Year to date | +15.3% | −13.5% |
| 1 year | −21.8% | +5.2% |
| Revenue growth (YoY) | +259.3% | +5.9% |
| Gross margin | 93.3% | 100.0% |
| Net margin | −225.1% | −654.3% |
| P/E (TTM) | — | — |
| Price / sales | 19.1× | 62.8× |
| Net cash | $617.6M | $319.2M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | 47.9% |
| Short % of float | 12.2% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).